Healthcare

HB 1816 requires Oklahoma's Medicaid program to prioritize in-state medical providers for in-person care when local options are available, rather than contracting with out-of-state providers. It specifically applies to services requiring the patient's physical presence and direct provider care (excluding remote services like lab work). The Oklahoma Health Care Authority must seek federal approval to implement this change. The bill takes effect November 1, 2025.

HB 2087 modifies Oklahoma's income tax credit for donations to qualified research institutes. It adjusts annual funding caps: for biomedical research institutes, the limit drops from $2 million to $1.5 million per year starting in 2026, while cancer research institute credits are capped at $500,000 annually. The credit percentage for each donation type is recalculated yearly based on prior-year claims, using specific formulas to stay within these new limits. Taxpayers donating to qualifying nonprofit biomedical or cancer research institutes (defined by NIH funding requirements) can claim the credit, with individual limits of $1,000-$25,000 depending on filing status or business type.

HB 1380 creates Oklahoma's Insulin Access and Affordability Program within the State Department of Health to lower insulin costs and improve access. The program requires the state to partner with nonprofit pharmaceutical companies and organizations to secure fast-acting insulin at capped prices: $30 per vial or $55 per pack of five pre-filled pens, with agreements detailing projected savings for Oklahoma residents and self-insured plans. It directly affects Oklahomans using insulin, particularly those on public or private insurance, by aiming to reduce out-of-pocket costs through competitive pricing. The program takes effect July 1, 2025, and requires nonprofits to commit to specific price points and savings reporting.

HB 2754 establishes the Oklahoma Rural Hospitals Funding Assistance Grant Program to provide financial support to qualifying rural hospitals. It directly affects publicly owned hospitals in towns with fewer than 5,000 residents that meet federal critical access hospital standards. The program creates a revolving fund in the state treasury, administered by the State Department of Health, to award grants prioritizing areas with significant healthcare access barriers due to distance. Grants are limited to the total funds available in the revolving fund, and the program becomes effective July 1, 2025.